Table 2.

Mean fidelity and distribution of fidelity scores for each practice at baseline and after 18 months

Scores for all sites at baseline	Sites	Fidelity score	Distribution of fidelity scores for sites N (%)
		Mean (95% CI)	1.00	1.01–1.99	2.00–2.99	3.00–3.99	4.00–4.99	5.00
Physical health care	26	2.05 (1.87; 2.22)	0 (0.0)	14 (53.8)	12 (46.2)	0 (0.0)	0 (0.0)	0 (0.0)
Antipsychotic medication management	17	2.41 (2.21; 2.61)	0 (0.0)	2 (11.8)	14 (82.3)	1 (5.9)	0 (0.0)	0 (0.0)
Family psychoeducation	14	1.66 (1.07; 2.26)	5 (35.7)	5 (35.7)	2 (14.3)	1 (7.1)	1 (7.1)	0 (0.0)
Illness management and recovery (IMR)	21	1.34 (0.91; 1.78)	17 (81.0)	1 (4.8)	2 (9.5)	0 (0.0)	0 (0.0)	1 (4,8)
All four practices	39 × 2	1.87 (1.68; 2.05)	22 (26.2)	22 (26.2)	30 (38.5)	2 (2.6)	1 (1.3)	1 (1.3)
Fidelity scores for groups of sites at 18 months
Experimental sites
Physical health care	13	2.87 (2.51; 3.23)	0 (0.0)	1 (7.7)	6 (46.2)	6 (46.2)	0 (0.0)	0 (0.0)
Antipsychotic medication management	8	3.19 (2.76; 3.62)	0 (0.0)	0 (0.0)	2 (25.0)	6 (75.0)	0 (0.0)	0 (0.0)
Family psychoeducation	7	3.31 (2.00; 4.61)	0 (0.0)	2 (28.6)	0 (0.0)	2 (28.6)	3 (42.9)	0 (0.0)
Illness management and recovery (IMR)	11	4.50 (3.86; 5.15)	0 (0.0)	1 (9.1)	0 (0.0)	0 (0.0)	8 (72.7)	2 (18.2)
All experimental sites	39	3.47 (3.12; 3.83)	0 (0.0)	4 (10.3)	8 (20.5)	14 (35.9)	11 (28.2)	2 (5.1)
Control sites
Physical health care	13	2.52 (2.26; 2.79)	0 (0.0)	1 (7.7)	10 (76.9)	2 (15.4)	0 (0.0)	0 (0.0)
Antipsychotic medication management	9	3.21 (2.99; 3.42)	0 (0.0)	0 (0.0)	1 (11.1)	8 (88.9)	0 (0.0)	0 (0.0)
Family psychoeducation	7	1.85 (0.91; 2.78)	1 (14.3)	4 (57.1)	1 (14.3)	1 (14.3)	0 (0.0)	0 (0.0)
Illness management and recovery (IMR)	10	2.16 (1.03; 3.29)	5 (50.0)	2 (20.0)	0 (0.0)	1 (10.0)	2 (20.0)	0 (0.0)
All control sites	39	2.47 (2.13; 2.80)	6 (15.4)	7 (17.9)	12 (30.8)	12 (30.8)	2 (5.1)	0 (0.0)